Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1477 to 1488 of 1488 entries
Sorted by: Best Match Show Resources per page
Delayed Kinetics of IgG, but Not IgA, Antispike Antibodies in Transplant Recipients following SARS-CoV-2 Infection.

Journal of the American Society of Nephrology : JASN

Cravedi P, Ahearn P, Wang L, Yalamarti T, Hartzell S, Azzi Y, Menon MC, Jain A, Billah M, Fernandez-Vina M, Gebel HM, Woodle ES, Haddad NS, Morrison-Porter A, Lee FE, Sanz I, Akalin E, Girnita A, Maltzman JS.
PMID: 34599041
J Am Soc Nephrol. 2021 Oct 01; doi: 10.1681/ASN.2021040573. Epub 2021 Oct 01.

BACKGROUND: Kidney transplant recipients are at increased risk of severe outcomes during COVID-19. Antibodies against the virus are thought to offer protection, but a thorough characterization of anti-SARS-CoV-2 immune globulin isotypes in kidney transplant recipients following SARS-CoV-2 infection has...

Cite
Cravedi P, Ahearn P, Wang L, et al. Delayed Kinetics of IgG, but Not IgA, Antispike Antibodies in Transplant Recipients following SARS-CoV-2 Infection. J Am Soc Nephrol. 2021;doi: 10.1681/ASN.2021040573.
Cravedi, P., Ahearn, P., Wang, L., Yalamarti, T., Hartzell, S., Azzi, Y., Menon, M. C., Jain, A., Billah, M., Fernandez-Vina, M., Gebel, H. M., Woodle, E. S., Haddad, N. S., Morrison-Porter, A., Lee, F. E., Sanz, I., Akalin, E., Girnita, A., & Maltzman, J. S. (2021). Delayed Kinetics of IgG, but Not IgA, Antispike Antibodies in Transplant Recipients following SARS-CoV-2 Infection. Journal of the American Society of Nephrology : JASN, . https://doi.org/10.1681/ASN.2021040573
Cravedi, Paolo, et al. "Delayed Kinetics of IgG, but Not IgA, Antispike Antibodies in Transplant Recipients following SARS-CoV-2 Infection." Journal of the American Society of Nephrology : JASN vol. (2021). doi: https://doi.org/10.1681/ASN.2021040573
Cravedi P, Ahearn P, Wang L, Yalamarti T, Hartzell S, Azzi Y, Menon MC, Jain A, Billah M, Fernandez-Vina M, Gebel HM, Woodle ES, Haddad NS, Morrison-Porter A, Lee FE, Sanz I, Akalin E, Girnita A, Maltzman JS. Delayed Kinetics of IgG, but Not IgA, Antispike Antibodies in Transplant Recipients following SARS-CoV-2 Infection. J Am Soc Nephrol. 2021 Oct 01; doi: 10.1681/ASN.2021040573. Epub 2021 Oct 01. PMID: 34599041; PMCID: PMC8638399.
Copy Download .nbib Format: NLM
A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation.

Clinical cancer research : an official journal of the American Association for Cancer Research

Atrafi F, Boix O, Subbiah V, Diamond JR, Chawla SP, Tolcher AW, LoRusso PM, Eder JP, Gutierrez M, Sankhala K, Rajagopalan P, Genvresse I, Langer S, Mathijssen RHJ, Verweij J, Bruns I, Lolkema MP.
PMID: 34518310
Clin Cancer Res. 2021 Dec 01;27(23):6366-6375. doi: 10.1158/1078-0432.CCR-20-4185. Epub 2021 Sep 13.

PURPOSE: Monopolar spindle 1 (MPS1) kinase inhibitor, BAY 1217389 (BAY) synergizes with paclitaxel. This phase I study assessed the combination of BAY with paclitaxel using a novel randomized continuous reassessment method (rCRM) to improve dose determination.PATIENTS AND METHODS: Patients...

Cite
Atrafi F, Boix O, Subbiah V, et al. A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation. Clin Cancer Res. 2021;27(23):6366-6375doi: 10.1158/1078-0432.CCR-20-4185.
Atrafi, F., Boix, O., Subbiah, V., Diamond, J. R., Chawla, S. P., Tolcher, A. W., LoRusso, P. M., Eder, J. P., Gutierrez, M., Sankhala, K., Rajagopalan, P., Genvresse, I., Langer, S., Mathijssen, R. H. J., Verweij, J., Bruns, I., & Lolkema, M. P. (2021). A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(23), 6366-6375. https://doi.org/10.1158/1078-0432.CCR-20-4185
Atrafi, Florence, et al. "A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,23 (2021): 6366-6375. doi: https://doi.org/10.1158/1078-0432.CCR-20-4185
Atrafi F, Boix O, Subbiah V, Diamond JR, Chawla SP, Tolcher AW, LoRusso PM, Eder JP, Gutierrez M, Sankhala K, Rajagopalan P, Genvresse I, Langer S, Mathijssen RHJ, Verweij J, Bruns I, Lolkema MP. A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation. Clin Cancer Res. 2021 Dec 01;27(23):6366-6375. doi: 10.1158/1078-0432.CCR-20-4185. Epub 2021 Sep 13. PMID: 34518310.
Copy Download .nbib Format: NLM
Equality of Ultradifferentiable Classes by Means of Indices of Mixed O-regular Variation.

Results in mathematics

Jiménez-Garrido J, Sanz J, Schindl G.
PMID: 34924811
Results Math. 2022;77(1):28. doi: 10.1007/s00025-021-01566-4. Epub 2021 Dec 04.

We characterize the equality between ultradifferentiable function classes defined in terms of abstractly given weight matrices and in terms of the corresponding matrix of associated weight functions by using new growth indices. These indices, defined by means of weight...

Cite
Jiménez-Garrido J, Sanz J, Schindl G. Equality of Ultradifferentiable Classes by Means of Indices of Mixed O-regular Variation. Results Math. 2021;77(1):28doi: 10.1007/s00025-021-01566-4.
Jiménez-Garrido, J., Sanz, J., & Schindl, G. (2022). Equality of Ultradifferentiable Classes by Means of Indices of Mixed O-regular Variation. Results in mathematics, 77(1), 28. https://doi.org/10.1007/s00025-021-01566-4
Jiménez-Garrido, Javier, et al. "Equality of Ultradifferentiable Classes by Means of Indices of Mixed O-regular Variation." Results in mathematics vol. 77,1 (2022): 28. doi: https://doi.org/10.1007/s00025-021-01566-4
Jiménez-Garrido J, Sanz J, Schindl G. Equality of Ultradifferentiable Classes by Means of Indices of Mixed O-regular Variation. Results Math. 2022;77(1):28. doi: 10.1007/s00025-021-01566-4. Epub 2021 Dec 04. PMID: 34924811; PMCID: PMC8643302.
Copy Download .nbib Format: NLM
An [FeIII30] molecular metal oxide.

Chemical communications (Cambridge, England)

Dearle AE, Cutler DJ, Coletta M, Lee E, Dey S, Sanz S, Fraser HWL, Nichol GS, Rajaraman G, Schnack J, Cronin L, Brechin EK.
PMID: 34807967
Chem Commun (Camb). 2021 Dec 21;58(1):52-55. doi: 10.1039/d1cc06224g.

Dissolution of FeBr

Cite
Dearle AE, Cutler DJ, Coletta M, et al. An [FeIII30] molecular metal oxide. Chem Commun (Camb). 2021;58(1):52-55doi: 10.1039/d1cc06224g.
Dearle, A. E., Cutler, D. J., Coletta, M., Lee, E., Dey, S., Sanz, S., Fraser, H. W. L., Nichol, G. S., Rajaraman, G., Schnack, J., Cronin, L., & Brechin, E. K. (2021). An [FeIII30] molecular metal oxide. Chemical communications (Cambridge, England), 58(1), 52-55. https://doi.org/10.1039/d1cc06224g
Dearle, Alice E, et al. "An [FeIII30] molecular metal oxide." Chemical communications (Cambridge, England) vol. 58,1 (2021): 52-55. doi: https://doi.org/10.1039/d1cc06224g
Dearle AE, Cutler DJ, Coletta M, Lee E, Dey S, Sanz S, Fraser HWL, Nichol GS, Rajaraman G, Schnack J, Cronin L, Brechin EK. An [FeIII30] molecular metal oxide. Chem Commun (Camb). 2021 Dec 21;58(1):52-55. doi: 10.1039/d1cc06224g. PMID: 34807967.
Copy Download .nbib Format: NLM
Late Recovery of Parathyroid Function After Total Thyroidectomy: A Case-Control Study.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

Díez JJ, Anda E, Sastre J, Corral BP, Álvarez-Escolá C, Manjón L, Paja M, Sambo M, Fernández PS, Carrera CB, Galofré JC, Navarro E, Zafón C, Sanz E, Oleaga A, Bandrés O, Donnay S, Megía A, Picallo M, Ragnarsson CS, Baena-Nieto G, Fernández-García JC, Lecumberri B, de la Vega MS, Romero-Lluch AR, Iglesias P.
PMID: 34517416
Horm Metab Res. 2021 Oct;53(10):654-661. doi: 10.1055/a-1608-1373. Epub 2021 Sep 13.

The clinical characteristics of patients with postoperative hypoparathyroidism who recover parathyroid function more than 12 months after surgery have not been studied. We aimed to evaluate whether the intensity of replacement therapy with calcium and calcitriol is related to...

Cite
Díez JJ, Anda E, Sastre J, et al. Late Recovery of Parathyroid Function After Total Thyroidectomy: A Case-Control Study. Horm Metab Res. 2021;53(10):654-661doi: 10.1055/a-1608-1373.
Díez, J. J., Anda, E., Sastre, J., Corral, B. P., Álvarez-Escolá, C., Manjón, L., Paja, M., Sambo, M., Fernández, P. S., Carrera, C. B., Galofré, J. C., Navarro, E., Zafón, C., Sanz, E., Oleaga, A., Bandrés, O., Donnay, S., Megía, A., Picallo, M., Ragnarsson, C. S., Baena-Nieto, G., Fernández-García, J. C., Lecumberri, B., de la Vega, M. S., Romero-Lluch, A. R., & Iglesias, P. (2021). Late Recovery of Parathyroid Function After Total Thyroidectomy: A Case-Control Study. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 53(10), 654-661. https://doi.org/10.1055/a-1608-1373
Díez, Juan José, et al. "Late Recovery of Parathyroid Function After Total Thyroidectomy: A Case-Control Study." Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme vol. 53,10 (2021): 654-661. doi: https://doi.org/10.1055/a-1608-1373
Díez JJ, Anda E, Sastre J, Corral BP, Álvarez-Escolá C, Manjón L, Paja M, Sambo M, Fernández PS, Carrera CB, Galofré JC, Navarro E, Zafón C, Sanz E, Oleaga A, Bandrés O, Donnay S, Megía A, Picallo M, Ragnarsson CS, Baena-Nieto G, Fernández-García JC, Lecumberri B, de la Vega MS, Romero-Lluch AR, Iglesias P. Late Recovery of Parathyroid Function After Total Thyroidectomy: A Case-Control Study. Horm Metab Res. 2021 Oct;53(10):654-661. doi: 10.1055/a-1608-1373. Epub 2021 Sep 13. PMID: 34517416.
Copy Download .nbib Format: NLM
Autoantibodies targeting LINE-1-encoded ORF1p are associated with systemic lupus erythematosus diagnosis but not disease activity.

Clinical and experimental rheumatology

Antiochos B, Paz M, Li J, Goldman DW, Petri M, Darrah E, Cashman K, Sanz I, Burns KH, Ardeljan D, Andrade F, Rosen A.
PMID: 34665712
Clin Exp Rheumatol. 2021 Oct 13; Epub 2021 Oct 13.

OBJECTIVES: Long Interspersed Element 1 (LINE-1) is an endogenous retroelement that constitutes a significant portion of the human genome and has been implicated in the pathogenesis of systemic lupus erythematosus (SLE). The LINE-1 RNA chaperone protein ORF1p was recently...

Cite
Antiochos B, Paz M, Li J, et al. Autoantibodies targeting LINE-1-encoded ORF1p are associated with systemic lupus erythematosus diagnosis but not disease activity. Clin Exp Rheumatol. 2021;
Antiochos, B., Paz, M., Li, J., Goldman, D. W., Petri, M., Darrah, E., Cashman, K., Sanz, I., Burns, K. H., Ardeljan, D., Andrade, F., & Rosen, A. (2021). Autoantibodies targeting LINE-1-encoded ORF1p are associated with systemic lupus erythematosus diagnosis but not disease activity. Clinical and experimental rheumatology, .
Antiochos, Brendan, et al. "Autoantibodies targeting LINE-1-encoded ORF1p are associated with systemic lupus erythematosus diagnosis but not disease activity." Clinical and experimental rheumatology vol. (2021).
Antiochos B, Paz M, Li J, Goldman DW, Petri M, Darrah E, Cashman K, Sanz I, Burns KH, Ardeljan D, Andrade F, Rosen A. Autoantibodies targeting LINE-1-encoded ORF1p are associated with systemic lupus erythematosus diagnosis but not disease activity. Clin Exp Rheumatol. 2021 Oct 13; Epub 2021 Oct 13. PMID: 34665712.
Copy Download .nbib Format: NLM
Molecular Analysis of IL-5 Receptor Subunit Alpha as a Possible Pharmacogenetic Biomarker in Asthma.

Frontiers in medicine

Elena-Pérez S, Heredero-Jung DH, García-Sánchez A, Estravís M, Martin MJ, Ramos-González J, Triviño JC, Isidoro-García M, Sanz C, Dávila I.
PMID: 33644088
Front Med (Lausanne). 2021 Feb 11;7:624576. doi: 10.3389/fmed.2020.624576. eCollection 2020.

No abstract available.

Cite
Elena-Pérez S, Heredero-Jung DH, García-Sánchez A, et al. Molecular Analysis of IL-5 Receptor Subunit Alpha as a Possible Pharmacogenetic Biomarker in Asthma. Front Med (Lausanne). 2021;7:624576doi: 10.3389/fmed.2020.624576.
Elena-Pérez, S., Heredero-Jung, D. H., García-Sánchez, A., Estravís, M., Martin, M. J., Ramos-González, J., Triviño, J. C., Isidoro-García, M., Sanz, C., & Dávila, I. (2020). Molecular Analysis of IL-5 Receptor Subunit Alpha as a Possible Pharmacogenetic Biomarker in Asthma. Frontiers in medicine, 7624576. https://doi.org/10.3389/fmed.2020.624576
Elena-Pérez, Sandra, et al. "Molecular Analysis of IL-5 Receptor Subunit Alpha as a Possible Pharmacogenetic Biomarker in Asthma." Frontiers in medicine vol. 7 (2020): 624576. doi: https://doi.org/10.3389/fmed.2020.624576
Elena-Pérez S, Heredero-Jung DH, García-Sánchez A, Estravís M, Martin MJ, Ramos-González J, Triviño JC, Isidoro-García M, Sanz C, Dávila I. Molecular Analysis of IL-5 Receptor Subunit Alpha as a Possible Pharmacogenetic Biomarker in Asthma. Front Med (Lausanne). 2021 Feb 11;7:624576. doi: 10.3389/fmed.2020.624576. eCollection 2020. PMID: 33644088; PMCID: PMC7904892.
Copy Download .nbib Format: NLM
Safety and efficacy of a feed additive consisting of .

EFSA journal. European Food Safety Authority

, Bampidis V, Azimonti G, Bastos ML, Christensen H, Dusemund B, Fašmon Durjava M, Kouba M, López-Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Sanz Y, Villa RE, Woutersen R, Martelli G, Anguita M, Galobart J, Manini P, Tarrés-Call J, Pettenati E, Pizzo F.
PMID: 34322173
EFSA J. 2021 Jul 22;19(7):e06699. doi: 10.2903/j.efsa.2021.6699. eCollection 2021 Jul.

The additive Biosprint

Cite
, Bampidis V, Azimonti G, et al. Safety and efficacy of a feed additive consisting of . EFSA J. 2021;19(7):e06699doi: 10.2903/j.efsa.2021.6699.
, Bampidis, V., Azimonti, G., Bastos, M. L., Christensen, H., Dusemund, B., Fašmon Durjava, M., Kouba, M., López-Alonso, M., López Puente, S., Marcon, F., Mayo, B., Pechová, A., Petkova, M., Ramos, F., Sanz, Y., Villa, R. E., Woutersen, R., Martelli, G., Anguita, M., Galobart, J., Manini, P., Tarrés-Call, J., Pettenati, E., & Pizzo, F. (2021). Safety and efficacy of a feed additive consisting of . EFSA journal. European Food Safety Authority, 19(7), e06699. https://doi.org/10.2903/j.efsa.2021.6699
, et al. "Safety and efficacy of a feed additive consisting of ." EFSA journal. European Food Safety Authority vol. 19,7 (2021): e06699. doi: https://doi.org/10.2903/j.efsa.2021.6699
, Bampidis V, Azimonti G, Bastos ML, Christensen H, Dusemund B, Fašmon Durjava M, Kouba M, López-Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Sanz Y, Villa RE, Woutersen R, Martelli G, Anguita M, Galobart J, Manini P, Tarrés-Call J, Pettenati E, Pizzo F. Safety and efficacy of a feed additive consisting of . EFSA J. 2021 Jul 22;19(7):e06699. doi: 10.2903/j.efsa.2021.6699. eCollection 2021 Jul. PMID: 34322173; PMCID: PMC8295886.
Copy Download .nbib Format: NLM
Safety and efficacy of a feed additive consisting of .

EFSA journal. European Food Safety Authority

, Bampidis V, Azimonti G, Bastos ML, Christensen H, Dusemund B, Fašmon Durjava M, Kouba M, López-Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Sanz Y, Villa RE, Woutersen R, Cocconcelli PS, Glandorf B, Maradona MP, Saarela M, Brozzi R, Galobart J, Innocenti M, Revez J.
PMID: 34322174
EFSA J. 2021 Jul 23;19(7):e06700. doi: 10.2903/j.efsa.2021.6700. eCollection 2021 Jul.

Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of

Cite
, Bampidis V, Azimonti G, et al. Safety and efficacy of a feed additive consisting of . EFSA J. 2021;19(7):e06700doi: 10.2903/j.efsa.2021.6700.
, Bampidis, V., Azimonti, G., Bastos, M. L., Christensen, H., Dusemund, B., Fašmon Durjava, M., Kouba, M., López-Alonso, M., López Puente, S., Marcon, F., Mayo, B., Pechová, A., Petkova, M., Ramos, F., Sanz, Y., Villa, R. E., Woutersen, R., Cocconcelli, P. S., Glandorf, B., Maradona, M. P., Saarela, M., Brozzi, R., Galobart, J., Innocenti, M., & Revez, J. (2021). Safety and efficacy of a feed additive consisting of . EFSA journal. European Food Safety Authority, 19(7), e06700. https://doi.org/10.2903/j.efsa.2021.6700
, et al. "Safety and efficacy of a feed additive consisting of ." EFSA journal. European Food Safety Authority vol. 19,7 (2021): e06700. doi: https://doi.org/10.2903/j.efsa.2021.6700
, Bampidis V, Azimonti G, Bastos ML, Christensen H, Dusemund B, Fašmon Durjava M, Kouba M, López-Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Sanz Y, Villa RE, Woutersen R, Cocconcelli PS, Glandorf B, Maradona MP, Saarela M, Brozzi R, Galobart J, Innocenti M, Revez J. Safety and efficacy of a feed additive consisting of . EFSA J. 2021 Jul 23;19(7):e06700. doi: 10.2903/j.efsa.2021.6700. eCollection 2021 Jul. PMID: 34322174; PMCID: PMC8299352.
Copy Download .nbib Format: NLM
Safety and efficacy of a feed additive consisting of l-lysine sulfate produced by .

EFSA journal. European Food Safety Authority

, Bampidis V, Azimonti G, Bastos ML, Christensen H, Dusemund B, Fašmon Durjava M, Kouba M, López-Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Sanz Y, Villa RE, Woutersen R, Anguita M, Brozzi R, Galobart J, Pettenati E, Tarrés-Call J.
PMID: 34322178
EFSA J. 2021 Jul 23;19(7):e06706. doi: 10.2903/j.efsa.2021.6706. eCollection 2021 Jul.

Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of l-lysine sulfate produced by

Cite
, Bampidis V, Azimonti G, et al. Safety and efficacy of a feed additive consisting of l-lysine sulfate produced by . EFSA J. 2021;19(7):e06706doi: 10.2903/j.efsa.2021.6706.
, Bampidis, V., Azimonti, G., Bastos, M. L., Christensen, H., Dusemund, B., Fašmon Durjava, M., Kouba, M., López-Alonso, M., López Puente, S., Marcon, F., Mayo, B., Pechová, A., Petkova, M., Ramos, F., Sanz, Y., Villa, R. E., Woutersen, R., Anguita, M., Brozzi, R., Galobart, J., Pettenati, E., & Tarrés-Call, J. (2021). Safety and efficacy of a feed additive consisting of l-lysine sulfate produced by . EFSA journal. European Food Safety Authority, 19(7), e06706. https://doi.org/10.2903/j.efsa.2021.6706
, et al. "Safety and efficacy of a feed additive consisting of l-lysine sulfate produced by ." EFSA journal. European Food Safety Authority vol. 19,7 (2021): e06706. doi: https://doi.org/10.2903/j.efsa.2021.6706
, Bampidis V, Azimonti G, Bastos ML, Christensen H, Dusemund B, Fašmon Durjava M, Kouba M, López-Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Sanz Y, Villa RE, Woutersen R, Anguita M, Brozzi R, Galobart J, Pettenati E, Tarrés-Call J. Safety and efficacy of a feed additive consisting of l-lysine sulfate produced by . EFSA J. 2021 Jul 23;19(7):e06706. doi: 10.2903/j.efsa.2021.6706. eCollection 2021 Jul. PMID: 34322178; PMCID: PMC8299270.
Copy Download .nbib Format: NLM
Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations.

British journal of haematology

Martín I, Villamón E, Abellán R, Calasanz MJ, Irigoyen A, Sanz G, Such E, Mora E, Gutiérrez M, Collado R, García-Serra R, Vara M, Blanco ML, Oiartzabal I, Álvarez S, Bernal T, Granada I, Xicoy B, Jerez A, Calabuig M, Diez R, Gil Á, Díez-Campelo M, Solano C, Tormo M.
PMID: 34296432
Br J Haematol. 2021 Aug;194(4):708-717. doi: 10.1111/bjh.17675. Epub 2021 Jul 22.

In myelodysplastic syndromes (MDS), the 20q deletion [del(20q)] may cause deletion of the ASXL1 gene. We studied 153 patients with MDS and del(20q) to assess the incidence, prognostic value and impact on response to azacitidine (AZA) of ASXL1 chromosomal...

Cite
Martín I, Villamón E, Abellán R, et al. Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations. Br J Haematol. 2021;194(4):708-717doi: 10.1111/bjh.17675.
Martín, I., Villamón, E., Abellán, R., Calasanz, M. J., Irigoyen, A., Sanz, G., Such, E., Mora, E., Gutiérrez, M., Collado, R., García-Serra, R., Vara, M., Blanco, M. L., Oiartzabal, I., Álvarez, S., Bernal, T., Granada, I., Xicoy, B., Jerez, A., Calabuig, M., Diez, R., Gil, �. �., Díez-Campelo, M., Solano, C., Tormo, M. (2021). Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations. British journal of haematology, 194(4), 708-717. https://doi.org/10.1111/bjh.17675
Martín, Iván, et al. "Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations." British journal of haematology vol. 194,4 (2021): 708-717. doi: https://doi.org/10.1111/bjh.17675
Martín I, Villamón E, Abellán R, Calasanz MJ, Irigoyen A, Sanz G, Such E, Mora E, Gutiérrez M, Collado R, García-Serra R, Vara M, Blanco ML, Oiartzabal I, Álvarez S, Bernal T, Granada I, Xicoy B, Jerez A, Calabuig M, Diez R, Gil Á, Díez-Campelo M, Solano C, Tormo M. Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations. Br J Haematol. 2021 Aug;194(4):708-717. doi: 10.1111/bjh.17675. Epub 2021 Jul 22. PMID: 34296432.
Copy Download .nbib Format: NLM
hGLUTEN Tool: Measuring Its Social Impact Indicators.

International journal of environmental research and public health

Moreno A, Sanz G, Garcia-Zapirain B.
PMID: 34886446
Int J Environ Res Public Health. 2021 Dec 02;18(23). doi: 10.3390/ijerph182312722.

hGLUTEN is a technological solution capable of detecting gluten and spoiled food. We measured the social impact of the hGLUTEN tool using two Likert scale surveys with two groups: professionals (engineers/chefs) and end-users. These data have been assessed in...

Cite
Moreno A, Sanz G, Garcia-Zapirain B. hGLUTEN Tool: Measuring Its Social Impact Indicators. Int J Environ Res Public Health. 2021;18(23)doi: 10.3390/ijerph182312722.
Moreno, A., Sanz, G., & Garcia-Zapirain, B. (2021). hGLUTEN Tool: Measuring Its Social Impact Indicators. International journal of environmental research and public health, 18(23), . https://doi.org/10.3390/ijerph182312722
Moreno, Antonia, et al. "hGLUTEN Tool: Measuring Its Social Impact Indicators." International journal of environmental research and public health vol. 18,23 (2021). doi: https://doi.org/10.3390/ijerph182312722
Moreno A, Sanz G, Garcia-Zapirain B. hGLUTEN Tool: Measuring Its Social Impact Indicators. Int J Environ Res Public Health. 2021 Dec 02;18(23). doi: 10.3390/ijerph182312722. PMID: 34886446; PMCID: PMC8657479.
Copy Download .nbib Format: NLM
Showing 1477 to 1488 of 1488 entries